Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease
- Daniel G. Bichet
- , Johannes M. Aerts
- , Christiane Auray-Blais
- , Hiroki Maruyama
- , Atul B. Mehta
- , Nina Skuban
- , Eva Krusinska
- , Raphael Schiffmann*
*Corresponding author for this work
- University of Montreal
- Leiden University
- Université de Sherbrooke
- Niigata University
- University College London
- Amicus Therapeutics, Cranbury, NJ, USA
- Baylor Scott & White Health
Research output: Contribution to journal › Article › Academic › peer-review